Filed: 11/14/2025ACC: 0001964437-25-000013
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $455.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
17
Positions
$455.97M
Total AUM (reported)
16.73M
Total Shares
Allocation by class
COM$313.47M68.7%
SPONSORED ADS$85.84M18.8%
SHS USD$39.62M8.7%
COM NEW$12.69M2.8%
ORDINARY SHARES$4.36M1.0%
Portfolio Concentration
Top 3$170.22M37.3%
4–10$182.72M40.1%
11–25$103.03M22.6%
Top 3 weight
37.3%
Top 10 weight
77.4%
Voting Authority Distribution
Total shares with voting rights: 16.73M
Sole
Full voting authority
16.73M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole17
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings17
Rows:
ABIVAX SA
SOLEShares801.22K
TypeSH
Market value$68.02M
14.92%
Sole
801.22K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares4.60M
TypeSH
Market value$62.58M
13.72%
Sole
4.60M
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares300.61K
TypeSH
Market value$39.62M
8.69%
Sole
300.61K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.67M
TypeSH
Market value$33.83M
7.42%
Sole
2.67M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares2.03M
TypeSH
Market value$29.08M
6.38%
Sole
2.03M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares788.44K
TypeSH
Market value$28.40M
6.23%
Sole
788.44K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares473.83K
TypeSH
Market value$23.41M
5.13%
Sole
473.83K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares579.89K
TypeSH
Market value$23.36M
5.12%
Sole
579.89K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares340.90K
TypeSH
Market value$22.53M
4.94%
Sole
340.90K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares886.33K
TypeSH
Market value$22.11M
4.85%
Sole
886.33K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares503.70K
TypeSH
Market value$20.22M
4.44%
Sole
503.70K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares734.54K
TypeSH
Market value$17.81M
3.91%
Sole
734.54K
Shared
0.00
None
0.00
MERUS N V
SOLEShares184.13K
TypeSH
Market value$17.34M
3.80%
Sole
184.13K
Shared
0.00
None
0.00
LENZ THERAPEUTICS INC
SOLEShares368.18K
TypeSH
Market value$17.15M
3.76%
Sole
368.18K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares1.15M
TypeSH
Market value$13.46M
2.95%
Sole
1.15M
Shared
0.00
None
0.00
MONOPAR THERAPEUTICS INC
SOLEShares155.37K
TypeSH
Market value$12.69M
2.78%
Sole
155.37K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares153.15K
TypeSH
Market value$4.36M
0.96%
Sole
153.15K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SASOLE | SPONSORED ADS | 801.22K | SH | $68.02M 14.92% | 801.22K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 4.60M | SH | $62.58M 13.72% | 4.60M | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 300.61K | SH | $39.62M 8.69% | 300.61K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.67M | SH | $33.83M 7.42% | 2.67M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 2.03M | SH | $29.08M 6.38% | 2.03M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 788.44K | SH | $28.40M 6.23% | 788.44K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 473.83K | SH | $23.41M 5.13% | 473.83K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 579.89K | SH | $23.36M 5.12% | 579.89K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 340.90K | SH | $22.53M 4.94% | 340.90K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 886.33K | SH | $22.11M 4.85% | 886.33K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 503.70K | SH | $20.22M 4.44% | 503.70K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 734.54K | SH | $17.81M 3.91% | 734.54K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 184.13K | SH | $17.34M 3.80% | 184.13K | 0.00 | 0.00 |
LENZ THERAPEUTICS INCSOLE | COM | 368.18K | SH | $17.15M 3.76% | 368.18K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 1.15M | SH | $13.46M 2.95% | 1.15M | 0.00 | 0.00 |
MONOPAR THERAPEUTICS INCSOLE | COM NEW | 155.37K | SH | $12.69M 2.78% | 155.37K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 153.15K | SH | $4.36M 0.96% | 153.15K | 0.00 | 0.00 |